Position in MRNA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,052,760
+$145,625 QoQ
Shares Held
15,033
-15.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#293
of 777 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Derivatives in MRNA
reported options exposure · as of Mar 31, 2024CallValue
$266,400
CallShares
2,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Arkadios Wealth Advisors holds $12,683,379 across 13 Biotechnology names. MRNA ranks #6 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,205 | $3,245,525 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
9,439 | $2,274,514 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,330 | $1,654,110 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
20,646 | $1,615,961 | |
| 5 | TYRA |
Tyra Biosciences, Inc.
|
49,336 | $1,575,791 | |
| 6 | MRNA |
Moderna, Inc.
This page
|
15,033 | $1,052,760 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
10,487 | $571,960 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
8,866 | $313,767 |
All Filings in MRNA
Export CSV
36 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,052,760 | 15,033 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $907,135 | 17,857 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $717,963 | 24,346 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $339,172 | 13,131 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $361,400 | 13,099 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $400,982 | 14,144 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $509,978 | 12,265 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $763,800 | 11,429 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1,328,337 | 11,186 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $266,400 | 2,500 | Call | Sole | 2024-04-30 | |
| 2024-03-31 | $1,161,930 | 10,904 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $725,985 | 7,300 | Call | Sole | 2024-01-24 | |
| 2023-12-31 | $1,167,344 | 11,738 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $1,289,988 | 12,489 | Shares | Sole | 2023-10-13 | |
| 2023-09-30 | $1,032,900 | 10,000 | Call | Sole | 2023-10-13 | |
| 2023-06-30 | $1,506,964 | 12,403 | Shares | Sole | 2023-07-26 | |
| 2023-06-30 | $607,500 | 5,000 | Call | Sole | 2023-07-26 | |
| 2023-03-31 | $767,900 | 5,000 | Call | Sole | 2023-05-02 | |
| 2023-03-31 | $2,031,095 | 13,225 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $449,050 | 2,500 | Call | Sole | 2023-01-11 | |
| 2022-12-31 | $2,393,795 | 13,327 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $1,581,830 | 13,377 | Shares | Sole | 2022-10-21 | |
| 2022-09-30 | $591,250 | 5,000 | Call | Sole | 2022-10-21 | |
| 2022-06-30 | $1,860,906 | 13,027 | Shares | Sole | 2022-07-14 | |
| 2022-06-30 | $1,928,475 | 13,500 | Call | Sole | 2022-07-14 | |
| 2022-03-31 | $1,291,950 | 7,500 | Call | Sole | 2022-05-02 | |
| 2022-03-31 | $2,242,308 | 13,017 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $3,074,681 | 12,106 | Shares | Sole | 2022-02-03 | |
| 2021-12-31 | $3,809,700 | 15,000 | Call | Sole | 2022-02-03 | |
| 2021-09-30 | $4,540,193 | 11,797 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $2,708,614 | 11,527 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $1,475,413 | 11,267 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $786,868 | 7,532 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $462,422 | 6,536 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $247,208 | 3,850 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $89,850 | 3,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||